In silico analysis of the interaction of de novo peptides derived from Salvia hispanica with anticancer targets

References

• Ahmad, A., Sayed, A., Ginnebaugh, K. R., Sharma, V., Suri, A., Saraph, A., Padhye, S., & Sarkar, F. H. (2015). Molecular docking and inhibition of matrix metalloproteinase-2 by novel difluorinatedbenzylidene curcumin analog. American Journal of Translational Research, 7(2), 298–308.
   PubMed Web of Science ®Google Scholar
• Aier, I., Varadwaj, P. K., & Raj, U. (2016). Structural insights into conformational stability of both wild-type and mutant EZH2 receptor. Scientific Reports, 6(1), 34984. https://doi.org/10.1038/srep34984
   PubMed Web of Science ®Google Scholar
• Altieri, D. C. (2015). Survivin – The inconvenient IAP. Seminars in Cell & Developmental Biology, 39, 91–96. https://doi.org/10.1016/j.semcdb.2014.12.007
   PubMed Web of Science ®Google Scholar
• Arslan, A. E., Arslan, O., & Kandemir, S. Y. (2021). AHP–TOPSIS hybrid decision-making analysis: Simav integrated system case study. Journal of Thermal Analysis and Calorimetry, 145(3), 1191–1202. https://doi.org/10.1007/s10973-020-10270-4
   Web of Science ®Google Scholar
• Avendaño López, C., & Menendez, J. C. (2015). Drugs that inhibit signaling pathways for tumor cell growth and proliferation. In Medicinal chemistry of anticancer drugs (2nd ed., pp. 391–491). Elsevier Science. https://doi.org/10.1016/B978-0-444-62649-3.00010-7
   Google Scholar
• Bakare, O. O., Fadaka, A. O., Keyster, M., & Pretorius, A. (2020). Structural and molecular docking analytical studies of the predicted ligand binding sites of cadherin-1 in cancer prognostics. Advances and Applications in Bioinformatics and Chemistry, 13, 1–9. https://doi.org/10.2147/AABC.S253851
   Google Scholar
• Bhandari, D., Rafiq, S., Gat, Y., Gat, P., Waghmare, R., & Kumar, V. (2020). A review on bioactive peptides: physiological functions, bioavailability and safety. International Journal of Peptide Research and Therapeutics, 26(1), 139–150. https://doi.org/10.1007/s10989-019-09823-5
   Web of Science ®Google Scholar
• Boice, A. G., Lopez, K. E., Pandita, R. K., Parsons, M. J., Charendoff, C. I., Charaka, V., Carisey, A. F., Pandita, T. K., & Bouchier-Hayes, L. (2022). Caspase-2 regulates S-phase cell cycle events to protect from DNA damage accumulation independent of apoptosis. Oncogene, 41(2), 204–219. https://doi.org/10.1038/s41388-021-02085-w
   PubMed Web of Science ®Google Scholar
• Boysen, M., Kityk, R., & Mayer, M. P. (2019). Hsp70- and Hsp90-mediated regulation of the conformation of p53 DNA binding domain and p53 cancer variants. Molecular Cell, 74(4), 831–843.e4. https://doi.org/10.1016/j.molcel.2019.03.032
   PubMed Web of Science ®Google Scholar
• Bruner, H. C., & Derksen, P. W. B. (2018). Loss of E-cadherin-dependent cell–cell adhesion and the development and progression of cancer. Cold Spring Harbor Perspectives in Biology, 10(3), a029330. https://doi.org/10.1101/cshperspect.a029330
   PubMed Web of Science ®Google Scholar
• Chai, J., Liu, J. N. K., & Ngai, E. W. T. (2013). Application of decision-making techniques in supplier selection: A systematic review of literature. Expert Systems with Applications, 40(10), 3872–3885. https://doi.org/10.1016/j.eswa.2012.12.040
   Web of Science ®Google Scholar
• Chiangjong, W., Chutipongtanate, S., & Hongeng, S. (2020). Anticancer peptide: Physicochemical property, functional aspect and trend in clinical application. International Journal of Oncology, 57(3), 678–696. https://doi.org/10.3892/ijo.2020.5099
   PubMed Web of Science ®Google Scholar
• Colomer, C., Pecharroman, I., Bigas, A., & Espinosa, L. (2020). Targeting IKKα kinase to prevent tumor progression and therapy resistance. Cancer Drug Resistance, 3(3), 482–490. https://doi.org/10.20517/cdr.2019.104
   PubMedGoogle Scholar
• da Cunha Santos, G., Shepherd, F. A., & Tsao, M. S. (2011). EGFR mutations and lung cancer. Annual Review of Pathology, 6, 49–69. https://doi.org/10.1146/annurev-pathol-011110-130206
   PubMed Web of Science ®Google Scholar
• Das, A. (2017). Advances in Chia seed research. Advances in Biotechnology & Microbiology, 5(2), 555661. https://doi.org/10.19080/AIBM.2017.05.555662
   Google Scholar
• Dehghani Soufi, M., Ghobadian, B., Najafi, G., Sabzimaleki, M. R., & Yusaf, T. (2015). TOPSIS multi-criteria decision modeling approach for biolubricant selection for two-stroke petrol engines. Energies, 8(12), 13960–13970. https://doi.org/10.3390/en81212408
   Web of Science ®Google Scholar
• Dimitrov, I., Flower, D. R., & Doytchinova, I. (2013). AllerTOP – A server for in silico prediction of allergens. BMC Bioinformatics, 14(S6), S4. https://doi.org/10.1186/1471-2105-14-S6-S4
   PubMedGoogle Scholar
• Du, Z., & Lovly, C. M. (2018). Mechanisms of receptor tyrosine kinase activation in cancer. Molecular Cancer, 17(1), 58. https://doi.org/10.1186/s12943-018-0782-4
   PubMed Web of Science ®Google Scholar
• Duffy, M. J., O'Donovan, N., Brennan, D. J., Gallagher, W. M., & Ryan, B. M. (2007). Survivin: A promising tumor biomarker. Cancer Letters, 249(1), 49–60. https://doi.org/10.1016/j.canlet.2006.12.020
   PubMed Web of Science ®Google Scholar
• Felício, M. R., Silva, O. N., Gonçalves, S., Santos, N. C., & Franco, O. L. (2017). Peptides with Dual Antimicrobial and Anticancer Activities. Frontiers in Chemistry, 5, 5. https://doi.org/10.3389/fchem.2017.00005
   PubMed Web of Science ®Google Scholar
• Ferreira, L. G., Dos Santos, R. N., Oliva, G., & Andricopulo, A. D. (2015). Molecular docking and structure-based drug design strategies. Molecules, 20(7), 13384–13421. https://doi.org/10.3390/molecules200713384
   PubMed Web of Science ®Google Scholar
• Fink, D., Schlagbauer-Wadl, H., Selzer, E., Lucas, T., Wolff, K., Pehamberger, H., Eichler, H.-G., & Jansen, B. (2001). Elevated procaspase levels in human melanoma. Melanoma Research, 11(4), 385–393. https://doi.org/10.1097/00008390-200108000-00009
   PubMed Web of Science ®Google Scholar
• Gaspar, D., Veiga, A. S., & Castanho, M. A. R. B. (2013). From antimicrobial to anticancer peptides. A review. Frontiers in Microbiology, 4, 294. https://doi.org/10.3389/fmicb.2013.00294
   PubMed Web of Science ®Google Scholar
• Gil-Kulik, P., Krzyżanowski, A., Dudzińska, E., Karwat, J., Chomik, P., Świstowska, M., Kondracka, A., Kwaśniewska, A., Cioch, M., Jojczuk, M., Nogalski, A., & Kocki, J. (2019). Potential involvement of BIRC5 in maintaining pluripotency and cell differentiation of human stem cells. Oxidative Medicine and Cellular Longevity, 2019, e8727925. https://doi.org/10.1155/2019/8727925
   PubMed Web of Science ®Google Scholar
• Gupta, U. K., Mahanta, S., & Paul, S. (2013). In silico design of small peptide-based Hsp90 inhibitor: A novel anticancer agent. Medical Hypotheses, 81(5), 853–861. https://doi.org/10.1016/j.mehy.2013.08.006
   PubMed Web of Science ®Google Scholar
• Henderson, V., Smith, B., Burton, L. J., Randle, D., Morris, M., & Odero-Marah, V. A. (2015). Snail promotes cell migration through PI3K/AKT-dependent Rac1 activation as well as PI3K/AKT-independent pathways during prostate cancer progression. Cell Adhesion & Migration, 9(4), 255–264. https://doi.org/10.1080/19336918.2015.1013383
   PubMed Web of Science ®Google Scholar
• Hill, M. M., & Hemmings, B. A. (2002). Inhibition of protein kinase B/Akt: Implications for cancer therapy. Pharmacology & Therapeutics, 93(2–3), 243–251. https://doi.org/10.1016/S0163-7258(02)00193-6
   PubMed Web of Science ®Google Scholar
• Hollingsworth, S. A., & Dror, R. O. (2018). Molecular dynamics simulation for all. Neuron, 99(6), 1129–1143. https://doi.org/10.1016/j.neuron.2018.08.011
   PubMed Web of Science ®Google Scholar
• Hoskin, D. W., & Ramamoorthy, A. (2008). Studies on anticancer activities of antimicrobial peptides. Biochimica et Biophysica Acta, 1778(2), 357–375. https://doi.org/10.1016/j.bbamem.2007.11.008
   PubMed Web of Science ®Google Scholar
• Huang, W.-Q., Lin, Q., Zhuang, X., Cai, L.-L., Ruan, R.-S., Lu, Z.-X., & Tzeng, C.-M. (2014). Structure, function, and pathogenesis of SHP2 in developmental disorders and tumorigenesis. Current Cancer Drug Targets, 14(6), 567–588. https://doi.org/10.2174/1568009614666140717105001
   PubMed Web of Science ®Google Scholar
• Huang, Y., Wang, X., Wang, H., Liu, Y., & Chen, Y. (2011). Studies on mechanism of action of anticancer peptides by modulation of hydrophobicity within a defined structural framework. Molecular Cancer Therapeutics, 10(3), 416–426. https://doi.org/10.1158/1535-7163.MCT-10-0811
   PubMed Web of Science ®Google Scholar
• Humphrey, W., Dalke, A., & Schulten, K. (1996). VMD: Visual molecular dynamics. Journal of Molecular Graphics, 14(1), 33–38. https://doi.org/10.1016/0263-7855(96)00018-5
   PubMedGoogle Scholar
• Jabeen, F., Panda, S. S., Kondratyuk, T. P., Park, E.-J., Pezzuto, J. M., Ihsan-ul-Haq, null, Hall, C. D., & Katritzky, A. R. (2015). Synthesis, molecular docking and anticancer studies of peptides and iso-peptides. Bioorganic & Medicinal Chemistry Letters, 25(15), 2980–2984. https://doi.org/10.1016/j.bmcl.2015.05.020
   PubMed Web of Science ®Google Scholar
• Jakubczyk, A., Karaś, M., Rybczyńska-Tkaczyk, K., Zielińska, E., & Zieliński, D. (2020). Current trends of bioactive peptides—New sources and therapeutic effect. Foods, 9(7), 846. https://doi.org/10.3390/foods9070846
   PubMed Web of Science ®Google Scholar
• James, J. K., Pike, D. H., Khan, I. J., & Nanda, V. (2018). Structural and dynamic properties of allergen and non-allergen forms of tropomyosin. Structure, 26(7), 997–1006.e5. https://doi.org/10.1016/j.str.2018.05.002
   PubMed Web of Science ®Google Scholar
• Jiang, H., & Li, H. (2021). Prognostic values of tumoral MMP2 and MMP9 overexpression in breast cancer: A systematic review and meta-analysis. BMC Cancer, 21(1), 149. https://doi.org/10.1186/s12885-021-07860-2
   PubMed Web of Science ®Google Scholar
• Kadel, S., Pellerin, G., Thibodeau, J., Perreault, V., Lainé, C., & Bazinet, L. (2019). How molecular weight cut-offs and physicochemical properties of polyether sulfone membranes affect peptide migration and selectivity during electrodialysis with filtration membranes. Membranes, 9(11), 153. https://doi.org/10.3390/membranes9110153
   PubMed Web of Science ®Google Scholar
• Kaszak, I., Witkowska-Piłaszewicz, O., Niewiadomska, Z., Dworecka-Kaszak, B., Ngosa Toka, F., & Jurka, P. (2020). Role of cadherins in cancer—A review. International Journal of Molecular Sciences, 21(20), 7624. https://doi.org/10.3390/ijms21207624
   PubMed Web of Science ®Google Scholar
• Krepela, E., Procházka, J., Liul, X., Fiala, P., & Kinkor, Z. (2004). Increased expression of Apaf-1 and procaspase-3 and the functionality of intrinsic apoptosis apparatus in non-small cell lung carcinoma. Biological Chemistry, 385(2), 153–168. https://doi.org/10.1515/BC.2004.034
   PubMed Web of Science ®Google Scholar
• Kojima, Y., Nakayama, M., Nishina, T., Nakano, H., Koyanagi, M., Takeda, K., Okumura, K., & Yagita, H. (2011). Importin β1 protein-mediated nuclear localization of death receptor 5 (DR5) limits DR5/tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL)-induced cell death of human tumor cells. The Journal of Biological Chemistry, 286(50), 43383–43393. https://doi.org/10.1074/jbc.M111.309377
   PubMed Web of Science ®Google Scholar
• Kostrzewa, T., Sahu, K. K., Gorska-Ponikowska, M., Tuszynski, J. A., & Kuban-Jankowska, A. (2018). Synthesis of small peptide compounds, molecular docking, and inhibitory activity evaluation against phosphatases PTP1B and SHP2. Drug Design, Development and Therapy, 12, 4139–4147. https://doi.org/10.2147/DDDT.S186614
   PubMed Web of Science ®Google Scholar
• Levine, A. J. (2020). p53: 800 Million years of evolution and 40 years of discovery. Nature Reviews Cancer, 20(8), 471–480. https://doi.org/10.1038/s41568-020-0262-1
   PubMed Web of Science ®Google Scholar
• Li, H., Qiu, Z., Li, F., & Wang, C. (2017). The relationship between MMP-2 and MMP-9 expression levels with breast cancer incidence and prognosis. Oncology Letters, 14(5), 5865–5870. https://doi.org/10.3892/ol.2017.6924
   PubMed Web of Science ®Google Scholar
• Li, P., Zhou, L., Zhao, T., Liu, X., Zhang, P., Liu, Y., Zheng, X., & Li, Q. (2017). Caspase-9: Structure, mechanisms and clinical application. Oncotarget, 8(14), 23996–24008. https://doi.org/10.18632/oncotarget.15098
   PubMedGoogle Scholar
• Liao, S., Li, J., Yu, L., & Sun, S. (2017). Protein tyrosine phosphatase 1B expression contributes to the development of breast cancer. Journal of Zhejiang University. Science. B, 18(4), 334–342. https://doi.org/10.1631/jzus.B1600184
   PubMed Web of Science ®Google Scholar
• Liscano, Y., Oñate-Garzón, J., & Delgado, J. P. (2020). Peptides with dual antimicrobial–anticancer activity: Strategies to overcome peptide limitations and rational design of anticancer peptides. Molecules, 25(18), 4245. Article 18. https://doi.org/10.3390/molecules25184245
   PubMed Web of Science ®Google Scholar
• Liu, H., Zhao, Z., Zhang, L., Li, Y., Jain, A., Barve, A., Jin, W., Liu, Y., Fetse, J., & Cheng, K. (2019). Discovery of low-molecular weight anti-PD-L1 peptides for cancer immunotherapy. Journal for Immunotherapy of Cancer, 7(1), 270. https://doi.org/10.1186/s40425-019-0705-y
   PubMed Web of Science ®Google Scholar
• Mantovani, F., Collavin, L., & Del Sal, G. (2019). Mutant p53 as a guardian of the cancer cell. Cell Death & Differentiation, 26(2), 199–212. https://doi.org/10.1038/s41418-018-0246-9
   PubMed Web of Science ®Google Scholar
• Martínez-Limón, A., Joaquin, M., Caballero, M., Posas, F., & de Nadal, E. (2020). The p38 pathway: From biology to cancer therapy. International Journal of Molecular Sciences, 21(6), 1913. https://doi.org/10.3390/ijms21061913
   PubMed Web of Science ®Google Scholar
• Miricescu, D., Diaconu, C., Stefani, C., Stanescu, A. M., Totan, A., Rusu, I., Bratu, O., Spinu, D., & Greabu, M. (2020). The serine/threonine protein kinase (Akt)/protein kinase B (PkB) signaling pathway in breast cancer. Journal of Mind and Medical Sciences, 7(1), 34–39. https://doi.org/10.22543/7674.71.P3439
   Web of Science ®Google Scholar
• Mishra, A., & Dey, S. (2019). Molecular docking studies of a cyclic octapeptide-cyclosaplin from sandalwood. Biomolecules, 9(11), 740. https://doi.org/10.3390/biom9110740
   PubMed Web of Science ®Google Scholar
• Mishra, A., Gauri, S. S., Mukhopadhyay, S. K., Chatterjee, S., Das, S. S., Mandal, S. M., & Dey, S. (2014). Identification and structural characterization of a new pro-apoptotic cyclic octapeptide cyclosaplin from somatic seedlings of Santalum album L. Peptides, 54, 148–158. https://doi.org/10.1016/j.peptides.2014.01.023
   PubMed Web of Science ®Google Scholar
• Mita, A. C., Mita, M. M., Nawrocki, S. T., & Giles, F. J. (2008). Survivin: Key regulator of mitosis and apoptosis and novel target for cancer therapeutics. Clinical Cancer Research, 14(16), 5000–5005. https://doi.org/10.1158/1078-0432.CCR-08-0746
   PubMed Web of Science ®Google Scholar
• Modi, S. J., & Kulkarni, V. M. (2019). Vascular endothelial growth factor receptor (VEGFR-2)/KDR inhibitors: Medicinal chemistry perspective. Medicine in Drug Discovery, 2, 100009. https://doi.org/10.1016/j.medidd.2019.100009
   Google Scholar
• Narayan, S., Mittal, A., & Vidhyapeeth, J. (2015). Salvia splendens roem ex schult: a review of phytochemical and pharmacological studies.
   Google Scholar
• Nayeb, A., Jabari, S., & Yousefi Nejad Attari, M. (2016). A combination of factor analysis and combined approach techniques (AHP-TOPSIS) for ranking criteria and evaluating the factors affecting brand.
   Google Scholar
• Nguyen, C., & Nguyen, V. D. (2016). Discovery of azurin-like anticancer bacteriocins from human gut microbiome through homology modeling and molecular docking against the tumor suppressor p53. BioMed Research International, 2016, 8490482. https://doi.org/10.1155/2016/8490482
   PubMed Web of Science ®Google Scholar
• O’Bryon, I., Jenson, S. C., & Merkley, E. D. (2020). Flying blind, or just flying under the radar? The underappreciated power of de novo methods of mass spectrometric peptide identification. Protein Science, 29(9), 1864–1878. https://doi.org/10.1002/pro.3919
   PubMed Web of Science ®Google Scholar
• O’Donovan, N., Crown, J., Stunell, H., Hill, A. D. K., McDermott, E., O’Higgins, N., & Duffy, M. J. (2003). Caspase 3 in breast cancer. Clinical Cancer Research, 9(2), 738–742.
   PubMed Web of Science ®Google Scholar
• Oelkrug, C., Hartke, M., & Schubert, A. (2015). Mode of action of anticancer peptides (ACPs) from amphibian origin. Anticancer Research, 35(2), 635–643.
   PubMed Web of Science ®Google Scholar
• Peng, Y.-H., Shiao, H.-Y., Tu, C.-H., Liu, P.-M., Hsu, J. T.-A., Amancha, P. K., Wu, J.-S., Coumar, M. S., Chen, C.-H., Wang, S.-Y., Lin, W.-H., Sun, H.-Y., Chao, Y.-S., Lyu, P.-C., Hsieh, H.-P., & Wu, S.-Y. (2013). Protein kinase inhibitor design by targeting the Asp-Phe-Gly (DFG) motif: The role of the DFG motif in the design of epidermal growth factor receptor inhibitors. Journal of Medicinal Chemistry, 56(10), 3889–3903. https://doi.org/10.1021/jm400072p
   PubMed Web of Science ®Google Scholar
• Persad, R., Liu, C., Wu, T.-T., Houlihan, P. S., Hamilton, S. R., Diehl, A. M., & Rashid, A. (2004). Overexpression of caspase-3 in hepatocellular carcinomas. Modern Pathology, 17(7), 861–867. https://doi.org/10.1038/modpathol.3800146
   PubMed Web of Science ®Google Scholar
• Phillips, J. C., Braun, R., Wang, W., Gumbart, J., Tajkhorshid, E., Villa, E., Chipot, C., Skeel, R. D., Kalé, L., & Schulten, K. (2005). Scalable molecular dynamics with NAMD. Journal of Computational Chemistry, 26(16), 1781–1802. https://doi.org/10.1002/jcc.20289
   PubMed Web of Science ®Google Scholar
• Popp, A., Wu, L., Keiderling, T. A., & Hauser, K. (2014). Effect of hydrophobic interactions on the folding mechanism of β-hairpins. The Journal of Physical Chemistry. B, 118(49), 14234–14242. https://doi.org/10.1021/jp506658x
   PubMed Web of Science ®Google Scholar
• Prescott, J. A., & Cook, S. J. (2018). Targeting IKKβ in cancer: Challenges and opportunities for the therapeutic utilisation of IKKβ inhibitors. Cells, 7(9), 115. PubMed https://doi.org/10.3390/cells7090115
   PubMed Web of Science ®Google Scholar
• Putt, K. S., Chen, G. W., Pearson, J. M., Sandhorst, J. S., Hoagland, M. S., Kwon, J.-T., Hwang, S.-K., Jin, H., Churchwell, M. I., Cho, M.-H., Doerge, D. R., Helferich, W. G., & Hergenrother, P. J. (2006). Small-molecule activation of procaspase-3 to caspase-3 as a personalized anticancer strategy. Nature Chemical Biology, 2(10), 543–550. https://doi.org/10.1038/nchembio814
   PubMed Web of Science ®Google Scholar
• Quintal-Bojórquez, N. d C., Carrillo-Cocom, L. M., Hernández-Álvarez, A. J., & Segura-Campos, M. R. (2021). Anticancer activity of protein fractions from chia (Salvia hispanica L.). Journal of Food Science, 86(7), 2861–2871. https://doi.org/10.1111/1750-3841.15780
   PubMed Web of Science ®Google Scholar
• Quintal-Bojórquez, N., & Segura-Campos, M. R. (2021). Bioactive peptides as therapeutic adjuvants for cancer. Nutrition and Cancer, 73(8), 1309–1321. https://doi.org/10.1080/01635581.2020.1813316
   PubMed Web of Science ®Google Scholar
• Qureshi, M. A., & Javed, S. (2021). Aflatoxin B1 induced structural and conformational changes in bovine serum albumin: A multispectroscopic and circular dichroism-based study. ACS Omega, 6(28), 18054–18064. https://doi.org/10.1021/acsomega.1c01799
   PubMed Web of Science ®Google Scholar
• Raghavan, V., Agrahari, M., & Gowda, D. K. (2019). Virtual screening of p53 mutants reveals Y220S as an additional rescue drug target for PhiKan083 with higher binding characteristics. Computational Biology and Chemistry, 80, 398–408. https://doi.org/10.1016/j.compbiolchem.2019.05.005
   PubMed Web of Science ®Google Scholar
• Rampogu, S., Baek, A., Park, C., Son, M., Parate, S., Parameswaran, S., Park, Y., Shaik, B., Kim, J. H., Park, S. J., & Lee, K. W. (2019). Discovery of small molecules that target vascular endothelial growth factor receptor-2 signalling pathway employing molecular modelling studies. Cells, 8(3), 269. https://doi.org/10.3390/cells8030269
   PubMed Web of Science ®Google Scholar
• Reva, B. A., Finkelstein, A. V., & Skolnick, J. (1998). What is the probability of a chance prediction of a protein structure with an RMSD of 6 Å? Folding & Design, 3(2), 141–147. https://doi.org/10.1016/S1359-0278(98)00019-4
   PubMedGoogle Scholar
• Sánchez Acosta, Y. A. (2016). Diseño de péptidos antimicrobianos derivados de Dermaseptina S4. Retrieved from https://repositorio.unal.edu.co/handle/unal/55719
   Google Scholar
• Sangande, F., Julianti, E., & Tjahjono, D. H. (2020). Ligand-based pharmacophore modeling, molecular docking, and molecular dynamic studies of dual tyrosine kinase inhibitor of EGFR and VEGFR2. International Journal of Molecular Sciences, 21(20), 7779. https://doi.org/10.3390/ijms21207779
   PubMed Web of Science ®Google Scholar
• Sanhueza, C., Wehinger, S., Castillo Bennett, J., Valenzuela, M., Owen, G. I., & Quest, A. F. G. (2015). The twisted survivin connection to angiogenesis. Molecular Cancer, 14(1), 198. https://doi.org/10.1186/s12943-015-0467-1
   PubMedGoogle Scholar
• Scodeller, P., & Asciutto, E. K. (2020). Targeting tumors using peptides. Molecules, 25(4), 808. https://doi.org/10.3390/molecules25040808
   PubMed Web of Science ®Google Scholar
• Shoombuatong, W., Schaduangrat, N., & Nantasenamat, C. (2018). Unraveling the bioactivity of anticancer peptides as deduced from machine learning. EXCLI Journal, 17, 734–752. https://doi.org/10.17179/excli2018-1447
   PubMed Web of Science ®Google Scholar
• Siahaan, P., Darmastuti, N., Aisyafalah, S., Sasongko, N., Hudiyanti, D., Asy’ari, M., & Prasasty, V. (2020). Probing the interaction between EC1-EC2 domain of E-cadherin with conformational structure of cyclic ADTC7 (Ac-CDTPDC-NH 2) peptide using molecular docking approach. Journal of Physics: Conference Series, 1524(1), 012081. https://doi.org/10.1088/1742-6596/1524/1/012081
   Google Scholar
• Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2021). Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians, 71(3), 209–249. https://doi.org/10.3322/caac.21660
   PubMed Web of Science ®Google Scholar
• Szymonowicz, K., Oeck, S., Malewicz, N. M., & Jendrossek, V. (2018). New insights into protein kinase B/Akt signaling: Role of localized Akt activation and compartment-specific target proteins for the cellular radiation response. Cancers, 10(3), 78. https://doi.org/10.3390/cancers10030078
   PubMed Web of Science ®Google Scholar
• Tran, N. H., Rahman, M. Z., He, L., Xin, L., Shan, B., & Li, M. (2016). Complete de novo assembly of monoclonal antibody sequences. Scientific Reports, 6(1), 31730. https://doi.org/10.1038/srep31730
   PubMedGoogle Scholar
• Tripathi, R. K. P., & Ayyannan, S. R. (2021). Emerging chemical scaffolds with potential SHP2 phosphatase inhibitory capabilities—A comprehensive review. Chemical Biology & Drug Design, 97(3), 721–773. https://doi.org/10.1111/cbdd.13807
   PubMed Web of Science ®Google Scholar
• Tu, M., Cheng, S., Lu, W., & Du, M. (2018). Advancement and prospects of bioinformatics analysis for studying bioactive peptides from food-derived protein: Sequence, structure, and functions. TrAC Trends in Analytical Chemistry, 105, 7–17. https://doi.org/10.1016/j.trac.2018.04.005
   Web of Science ®Google Scholar
• Wagner, E. F., & Nebreda, Á. R. (2009). Signal integration by JNK and p38 MAPK pathways in cancer development. Nature Reviews Cancer, 9(8), 537–549. https://doi.org/10.1038/nrc2694
   PubMed Web of Science ®Google Scholar
• Wang, F., Wang, L., Zhao, Y., Li, Y., Ping, G., Xiao, S., Chen, K., Zhu, W., Gong, P., Yang, J., & Wu, C. (2014). A novel small-molecule activator of procaspase-3 induces apoptosis in cancer cells and reduces tumor growth in human breast, liver and gallbladder cancer xenografts. Molecular Oncology, 8(8), 1640–1652. https://doi.org/10.1016/j.molonc.2014.06.015
   PubMed Web of Science ®Google Scholar
• Wang, H.-C., Chiang, W.-F., Huang, H.-H., Shen, Y.-Y., & Chiang, H.-C. (2014). Src-homology 2 domain-containing tyrosine phosphatase 2 promotes oral cancer invasion and metastasis. BMC Cancer, 14(1), 442. https://doi.org/10.1186/1471-2407-14-442
   PubMedGoogle Scholar
• Warrier, N. M., Agarwal, P., & Kumar, P. (2020). Emerging importance of survivin in stem cells and cancer: The development of new cancer therapeutics. Stem Cell Reviews and Reports, 16(5), 828–852. https://doi.org/10.1007/s12015-020-09995-4
   PubMed Web of Science ®Google Scholar
• Xue, L. C., Rodrigues, J. P., Kastritis, P. L., Bonvin, A. M., & Vangone, A. (2016). PRODIGY: A web server for predicting the binding affinity of protein–protein complexes. Bioinformatics, 32(23), 3676–3678. https://doi.org/10.1093/bioinformatics/btw514
   PubMed Web of Science ®Google Scholar
• Yadav, P., Yadav, R., Jain, S., & Vaidya, A. (2021). Caspase-3: A primary target for natural and synthetic compounds for cancer therapy. Chemical Biology & Drug Design, 98(1), 144–165. https://doi.org/10.1111/cbdd.13860
   PubMed Web of Science ®Google Scholar
• Yammine, S., Rabagliato, R., Vitrac, X., Peuchot, M. M., & Ghidossi, R. (2019). Selecting ultrafiltration membranes for fractionation of high added value compounds from grape pomace extracts. OENO One, 53(3). https://doi.org/10.20870/oeno-one.2019.53.3.2343
   Web of Science ®Google Scholar
• Yan, J.-D., Liu, Y., Zhang, Z.-Y., Liu, G.-Y., Xu, J.-H., Liu, L.-Y., & Hu, Y.-M. (2015). Expression and prognostic significance of VEGFR-2 in breast cancer. Pathology, Research and Practice, 211(7), 539–543. https://doi.org/10.1016/j.prp.2015.04.003
   PubMed Web of Science ®Google Scholar
• Yip, S.-C., Saha, S., & Chernoff, J. (2010). PTP1B: A double agent in metabolism and oncogenesis. Trends in Biochemical Sciences, 35(8), 442–449. https://doi.org/10.1016/j.tibs.2010.03.004
   PubMed Web of Science ®Google Scholar
• Yuan, J. P., Wang, L. W., Qu, A. P., Chen, J. M., Xiang, Q. M., Chen, C., Sun, S.-R., Pang, D.-W., Liu, J., & Li, Y. (2015). Quantum dots-based quantitative and in situ multiple imaging on Ki67 and cytokeratin to improve Ki67 assessment in breast cancer. PLOS One, 10(4), e0122734. https://doi.org/10.1371/journal.pone.0122734
   PubMed Web of Science ®Google Scholar
• Zarubin, T., & Han, J. (2005). Activation and signaling of the p38 MAP kinase pathway. Cell Research, 15(1), 11–18. https://doi.org/10.1038/sj.cr.7290257
   PubMed Web of Science ®Google Scholar
• Zhu, G., Pan, C., Bei, J.-X., Li, B., Liang, C., Xu, Y., & Fu, X. (2020). Mutant p53 in cancer progression and targeted therapies. Frontiers in Oncology,  10, 595187. https://doi.org/10.3389/fonc.2020.595187
   Web of Science ®Google Scholar